A reappraisal of the medical therapy with steroidogenesis inhibitors in Cushing's syndrome.
about
The Treatment of Cushing's Disease.Role of "old" pharmacological agents in the treatment of Cushing's syndromeUpdates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapiesEffectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 PatientsUpdate on medical treatment for Cushing's disease.Impact and timing of bilateral adrenalectomy for refractory adrenocorticotropic hormone-dependent Cushing’s syndromeCushing's syndrome: epidemiology and developments in disease management.Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice GuidelineEfficacy of medical treatment in Cushing's disease: a systematic review.Detection of recurrent Cushing's disease: proposal for standardized patient monitoring following transsphenoidal surgery.Medical therapy for Cushing's disease: adrenal steroidogenesis inhibitors and glucocorticoid receptor blockers.Emerging drugs for Cushing's disease.Cushing's syndrome: an update on current pharmacotherapy and future directions.Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly.Management of Cushing syndrome in children and adolescents: experience of a single tertiary centre.Increased long-term remission after adequate medical cortisol suppression therapy as presurgical treatment in Cushing's disease.A polymorphism in the CYP17A1 gene influences the therapeutic response to steroidogenesis inhibitors in Cushing's syndrome.Diabetes Mellitus Secondary to Cushing's Disease.
P2860
Q27010590-BECCD529-BC18-478B-ABB3-65E58CCDA251Q28067685-C9C12CEC-4D03-49BD-8CCB-3FA56EB1AD2FQ28076013-9CB9CBFA-5FA5-4031-A559-46DF6008A472Q33569920-186A5D99-6BF5-4D46-BE9E-051643B0603AQ33802284-8DB68FC2-EED2-48AE-904A-D05441BB704DQ34743189-80956BDE-3B08-4C8F-A136-6E5E0C771122Q35531889-EFE8D7E3-894A-49D9-9169-B6068F7D3842Q35916555-86E33F2F-12EF-44C5-A16B-B809E123B6DAQ38151882-5007A650-8FF8-4B2D-B99F-C149DC3FCA49Q38224779-B73578D3-1000-48DA-95D9-1A46AB89A8F7Q38307934-389D85C8-2B3A-49C0-BA5E-24EFBCF0B88FQ38505947-FCB52A46-5FE0-4304-A237-D75DC7568973Q38541695-2F721759-F160-4426-ADFC-51C0A7D3F36BQ38683309-C592DD98-0821-4408-B53A-81715F51DA6CQ38832377-F47654EB-C9D3-49B0-8F04-F3055F9198F1Q44042389-F5A55A91-A22B-454A-8031-AC70CC944124Q48194404-CDBA7476-0406-4608-A5E9-5BA0CBA42F71Q55425212-48081BE8-EE62-433B-BF2E-61E6C42198D8
P2860
A reappraisal of the medical therapy with steroidogenesis inhibitors in Cushing's syndrome.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
A reappraisal of the medical t ...... ibitors in Cushing's syndrome.
@en
A reappraisal of the medical t ...... ibitors in Cushing's syndrome.
@nl
type
label
A reappraisal of the medical t ...... ibitors in Cushing's syndrome.
@en
A reappraisal of the medical t ...... ibitors in Cushing's syndrome.
@nl
prefLabel
A reappraisal of the medical t ...... ibitors in Cushing's syndrome.
@en
A reappraisal of the medical t ...... ibitors in Cushing's syndrome.
@nl
P2860
P50
P1476
A reappraisal of the medical t ...... ibitors in Cushing's syndrome.
@en
P2093
Elena Valassi
José Rodríguez
P2860
P304
P356
10.1111/J.1365-2265.2012.04424.X
P577
2012-11-01T00:00:00Z